Turn Therapeutics, Inc. (TTRX)
4.68
+0.74
(+18.78%)
USD |
NASDAQ |
Jan 02, 16:00
4.68
0.00 (0.00%)
After-Hours: 18:36
Turn Therapeutics EPS Diluted (Quarterly): -0.068 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Nektar Therapeutics | -1.875 |
| Bluejay Diagnostics, Inc. | -1.015 |
| Apogee Therapeutics, Inc. | -1.106 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.904M |
| Total Expenses (Quarterly) | 1.904M |